Overview
Discordant atrioventricular (AV) connection refers to an abnormal electrical pathway between the atria and ventricles that can lead to various arrhythmias, particularly orthodromic tachycardia. Catheter ablation is a common therapeutic approach for managing these conditions 1.Diagnosis
Electrophysiology Study: Essential for confirming the presence and characteristics of the accessory AV connection 12.
Inducible Tachycardia: Presence of inducible sustained tachycardia during electrophysiologic testing supports the diagnosis 2.
Electrocardiogram (ECG) Findings: May show specific patterns indicative of accessory pathways, though definitive diagnosis often requires invasive studies 1.Management
Catheter Ablation: First-line treatment using high-energy shocks (200-400 J) delivered via specific electrode configurations; success rate varies but can be high, especially for concealed connections 1.
Drug Therapy: Quinidine can be used pre-ablation to prolong refractoriness and slow conduction through the accessory pathway, though efficacy can be reversed by epinephrine 2.
Adjunctive Use of Epinephrine: May reverse electrophysiologic effects of quinidine, potentially restoring tachycardia inducibility 2.Special Populations
No Specific Data Provided: Abstracts do not cover management specifics for pregnancy, pediatrics, elderly, or comorbid conditions 12.Key Recommendations
Perform catheter ablation using high-energy shocks for patients with symptomatic discordant AV connections, targeting specific electrode placements for optimal efficacy (Evidence: Moderate 1).
Consider quinidine pre-ablation to modify electrophysiologic properties, though monitor for potential reversal by epinephrine (Evidence: Moderate 2).
Electrophysiology studies are crucial for both diagnosis and guiding therapeutic interventions, ensuring accurate assessment of accessory pathway characteristics (Evidence: Moderate 12).References
1 Morady F, Scheinman MM, Kou WH, Griffin JC, Dick M, Herre J et al.. Long-term results of catheter ablation of a posteroseptal accessory atrioventricular connection in 48 patients. Circulation 1989. link
2 Morady F, Kou WH, Kadish AH, Toivonen LK, Kushner JA, Schmaltz S. Effects of epinephrine in patients with an accessory atrioventricular connection treated with quinidine. The American journal of cardiology 1988. link90659-5)